Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported its financial results and business update for the three months ended June 30, 2017. Synergy will host a …
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) shares were on a 4% cave yesterday on the heels of Express Scripts setting loose its 2018 National Preferred …
Express Scripts, a company that controls about 40 percent of the pharmacy benefit market, will exclude an additional 64 drugs from its national …
BTIG analyst Tim Chiang is optimistic in regard to continued long-term growth at Synergy Pharmaceuticals Inc (NASDAQ:SGYP). The company is taking a number of …
Oppenheimer analyst Derek Archila sees some short-term capital rocky waters for Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and awaits more details post-Trulance launch, but continues to …
Second quarter earnings for the year are due sometime around mid-August from Synergy Pharmaceuticals Inc (NASDAQ:SGYP). Yet, for Canaccord analyst John Newman, consensus …
Sameul Isaly, founder of one of the world’s most well-known healthcare funds, has made two key moves on Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and …
BTIG analyst Tim Chiang was out today with a research note on drug maker Synergy Pharmaceuticals Inc (NASDAQ:SGYP), noting that SGYP’s chronic idiopathic constipation (CIC) drug Trulance …
Last week, Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) excited investors with the news that its drug Trulance, a treatment approved in the indication of Chronic …
Israel “Izzy” Englander is a self-made man living the American dream, whose Polish parents have since seen their son carve out a small …
